Algisyl-LVR® to be the subject of two scientific presentations at the 9th Conference on Cell Therapy for Cardiovascular Disease in New York City
News and Announcements
Watch a Video Interview following the report on the AUGMENT-HF heart failure clinical trial of Algisyl-LVR® presented at the 2013 Scientific Sessions of the American Heart Association in Dallas
LoneStar Heart Reports Positive Interim Results of Algisyl-LVR® for Advanced Heart Failure at AHA’s Late-Breaking Clinical Trials Sessions
An article has just been published in International Journal of Cardiology (In Press, Online Date: February 8th, 2013).
LoneStar Heart Inc.today announced the completion of an up to $20 million milestone-based equity financing to support the clinical testing and regulatory clearance of its lead product, Algisyl-LVR, a single-use, self-gelling biopolymer implanted into the heart’s left ventricle during surgery for the treatment of advanced heart failure. Themes Investment Partners (“Themes”), a Hong Kong-based private equity fund focused on China markets, led the round. The new financing brings up to $35 million in equity funding since the company’s founding in June 2010.
Press release - LoneStar Heart Inc. today announced the first patient was treated in the company’s international multi-center AUGMENT-HF clinical trial of Algisyl-LVR at IRCCS San Raffaele Pisana and at Umberto I Policlinico, both located in Rome, Italy.
LoneStar Heart Presents Abstract at the Annual Meeting of the Heart Failure Society of America. The text of the abstract is available from the Journal of Cardiac Failure here.
LoneStar Heart, Inc. Featured in Emerging Company Profile in BioCentury Magazine.
LAGUNA HILLS, Calif., May 29, 2012 —LoneStar Heart Inc., today announced the advancement of a new therapeutic strategy aimed at genetic reprogramming of cardiac fibroblasts into functioning heart muscle cells to treat damage following a heart attack and other forms of heart disease.
Data from LoneStar Heart's first-in-man study has recently been published in Cell Transplantation. Free full text for Lee et. al. "Polymer-based restoration of left ventricular mechanics" is available here.
LoneStar Heart sponsors Texans for Stem Cell Research's DFW area symposium "Learn For Life". LoneStar Heart scientific collaborators Dr. Eric Olsen and Dr. Jay Scheneider presented talks.
LoneStar Heart Acquires Worldwide Exclusive Rights to New Class of Small Molecules That May Lead to New Treatments for Diabetes
Click here to download press release (PDF)